Literature DB >> 11031265

Increased production of beta-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2.

N Sato1, K Imaizumi, T Manabe, M Taniguchi, J Hitomi, T Katayama, T Yoneda, T Morihara, Y Yasuda, T Takagi, T Kudo, T Tsuda, Y Itoyama, T Makifuchi, P E Fraser, P St George-Hyslop, M Tohyama.   

Abstract

An alternative spliced form of the presinilin 2 (PS2) gene (PS2V) lacking exon 5 has previously been reported to be expressed in human brains in sporadic Alzheimer's disease (AD). PS2V encodes the amino-terminal portion of PS2, which contains residues Met1-Leu119 and 5 additional amino acid residues (SSMAG) at its carboxyl terminus. Here we report that PS2V protein impaired the signaling pathway of the unfolded protein response, similarly to familial AD-linked PS1 mutants and caused significant increases in the production of both amyloid beta40 and beta42. Interestingly, PS2V-encoding protein was expressed in neuropathologically affected neurons of the hippocampal CA1 region and temporal cortex in AD patients. These findings suggest that the aberrant splicing of the PS2 gene may be implicated in the neuropathology of sporadic AD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11031265     DOI: 10.1074/jbc.M006886200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.

Authors:  Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Hyoung-gon Lee; George Perry; Xiongwei Zhu; Rudy J Castellani; Mark A Smith
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

2.  Presenilins regulate the cellular activity of ryanodine receptors differentially through isotype-specific N-terminal cysteines.

Authors:  Andrew J Payne; Bryan C Gerdes; Yuliya Naumchuk; Audrey E McCalley; Simon Kaja; Peter Koulen
Journal:  Exp Neurol       Date:  2013-09-09       Impact factor: 5.330

Review 3.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

Review 4.  Neuronal Ryanodine Receptors in Development and Aging.

Authors:  Nawaf Abu-Omar; Jogita Das; Vivian Szeto; Zhong-Ping Feng
Journal:  Mol Neurobiol       Date:  2017-01-19       Impact factor: 5.590

Review 5.  Tailoring of membrane proteins by alternative splicing of pre-mRNA.

Authors:  Kathleen F Mittendorf; Catherine L Deatherage; Melanie D Ohi; Charles R Sanders
Journal:  Biochemistry       Date:  2012-06-29       Impact factor: 3.162

Review 6.  Endoplasmic reticulum dysfunction in Alzheimer's disease.

Authors:  Jie-Qiong Li; Jin-Tai Yu; Teng Jiang; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-04-09       Impact factor: 5.590

7.  1,2-dilinoleoyl-sn-glycero-3-phosphoethanolamine ameliorates age-related spatial memory deterioration by preventing neuronal cell death.

Authors:  Takahiro Yaguchi; Tetsu Nagata; Tomoyuki Nishizaki
Journal:  Behav Brain Funct       Date:  2010-09-13       Impact factor: 3.759

8.  Promoter polymorphisms modulating HSPA5 expression may increase susceptibility to Taiwanese Alzheimer's disease.

Authors:  W-C Hsu; H-K Wang; L-C Lee; H-C Fung; J-C Lin; H-P Hsu; Y-R Wu; L-S Ro; F-J Hu; Y-T Chang; G-J Lee-Chen; C-M Chen
Journal:  J Neural Transm (Vienna)       Date:  2008-09-10       Impact factor: 3.575

9.  Two novel spliced presenilin 2 transcripts in human lymphocyte with oxidant stress and brain.

Authors:  Nobuyuki Takahashi; Shingo Kariya; Makito Hirano; Satoshi Ueno
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

10.  An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease.

Authors:  Reiko Onuki; Yoshio Bando; Eigo Suyama; Taiichi Katayama; Hiroaki Kawasaki; Tadashi Baba; Masaya Tohyama; Kazunari Taira
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.